EQUITY RESEARCH MEMO
Edge Medical
Generated 5/24/2026
Executive Summary
Conviction (model self-assessment)65/100
Edge Medical, based in Shenzhen, China, is a commercial-stage surgical robotics company specializing in minimally invasive systems. Founded in 2010, the company has developed a comprehensive platform including multi-port, single-port, and bronchoscopic surgical robots, complemented by a cloud-based telesurgery system. With 200–500 employees and a public listing, Edge Medical focuses on innovative solutions for endoscopic and bronchoscopic procedures, addressing the growing demand for precision surgery in China and globally. The company's technology aims to improve patient outcomes, reduce recovery times, and expand access to advanced surgical care through remote surgery capabilities.
Upcoming Catalysts (preview)
- Q4 2026NMPA approval for single-port surgical robot70% success
- H1 2027Distribution partnership for Southeast Asia expansion60% success
- Q2 2027Launch of next-generation telesurgery platform50% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)